Clinical trial
Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated…
NCT00437632 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00437632 |
|---|---|
| Title | Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809 |
| Official title | A Placebo Controlled, Single Blind, Randomised Study Investigating the Safety, Tolerability and Pharmacokinetics of Repeated Oral Doses of GSK598809 in Healthy Male and Female Volunteers for 28 Days. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Substance Dependence |
| Intervention type | Drug |
| Interventions | GSK598809, Placebo, Caffeine |
| Enrollment | 104 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 22, 2008 |
| Completion | Aug 22, 2008 |
| First posted | Feb 21, 2007 |
| Last update posted | Jul 31, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: